 |
 |
|
Alfacell Corporation is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE, is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. In addition to an ongoing Phase IIIb study in malignant mesothelioma, Alfacell is conducting a Phase I/II trial of ONCONASE in non-small cell lung cancer (NSCLC) and other solid tumors.
|
|
| Recent News |
|
|
June 19th, 2009
|
|
Alfacell Provides Shareholder Update
|
|
|
January 27th, 2009
|
|
Alfacell Provides ONCONASE(R) NDA Submission Update
|
|
|
January 5th, 2009
|
|
Alfacell Announces Receipt of NASDAQ Panel Decision
|
|
|
December 12th, 2008
|
|
Alfacell Announces Management Update
|
|
|
December 10th, 2008
|
|
Alfacell Reports Financial Results for First Quarter of Fiscal 2009
|
|
|
December 10th, 2008
|
|
Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells
|
|
|
Press Release Archive
|
|
All Archived Press Releases are now easily available for viewing
|
|
| Upcoming Events |
|
4th Fabisch-Symposium for Cancer Research and Molecular Cell Biology, 2nd Targeted Tumor Therapies: 01-03 April 2009, Berlin, Germany
2nd NIH Mesothelioma Conference: March 6, 2009 - Lipsett Auditorium - National Institutes of Health - Bethesda, MD
|
|
|
| Information Center |
|
|
Effect of Onconase on Double-Stranded RNA In Vitro
|
|
|
|
|
Local Controlled Delivery of Anti-Neoplastic RNAse to the Brain
|
|
|
|
|
Ranprinase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies
|
|
|
|
|
View animated model of the ONCONASE Mechanism in Action!
|
|
|
|
|
Dr. Harvey Pass, Alfacell Thoracic Cancer Advisory Board Member, on the CBS Evening News, October 25, 2006
|
|
|
|
|
Message from Tommy G. Thompson, former U.S. Secretary, Health and Human Services
|
|
|
|
|
Audit Committee Charter
|
|
|
|
|
Compensation Committee Charter
|
|
|
|
|
Corporate Governance and Nominating Committee Charter
|
|
|
|
|
1998-2008, Alfacell Corporation
300 Atrium Drive, Somerset, NJ 08873
Phone: 732-652-4525 Fax: 732-652-4575
Please read our Disclaimer
|
|
Home
Contact us
|
|